(TSX: HEO) – H2O Innovation Inc. (“H2O Innovation” or the
“Corporation”) announces its financial results for the third
quarter of fiscal year 2022 ended March 31, 2022.
“We have achieved revenue growth of 32.6% for
this third quarter, combining organic growth and acquisitions, in
line with our three-year strategic plan. Indeed, we are proud to
present sustained double-digit organic revenue growth in all three
of our business pillars. The expansion of our sales resources in
our Specialty Products business pillar combined with our
disciplined approach in the WTS business pillar and the successful
start-up and renewal of multiple O&M projects have clearly paid
off. Every day we continue to prove the value of our ESG-focused
business model by relying on clean technologies, green chemistry
and high-recurring revenues based on close customer relationships.
Despite highly volatile market conditions, measures are taken to
ensure the continuity of business and supply of products in the
most competitive way to serve our customers and preserve our gross
profit margins. Finally, the strategic renewal and scope of work
expansion for the city of Gulfport (Mississippi) as well as the
possible acquisition of Leader Evaporator, both announced after the
third quarter, set the tone for the upcoming quarters,”
stated Frédéric Dugré, President and Chief Executive
Officer of H2O
Innovation.
Third quarter results
H2O Innovation relies on three well-balanced
business pillars, which reduces the risk of volatility in the
Corporation’s revenues. Consolidated revenues from the
Corporation’s three business pillars for the three-month period
ended on March 31, 2022, increased by $12.7 M, or 32.6%, to reach
$51.9 M, compared to $39.2 M for the comparable quarter of the
previous fiscal year. These results were driven by organic revenue
growth2 of $6.0 M, or 15.3%, and acquisition growth of $6.7 M,
or 17.3%. This overall increase was partially fuelled by the
acquisition of JCO, Inc. (“JCO”) and Environmental Consultants,
L.L.C. (“EC”) on December 15, 2021, which contributed
$4.5 M in revenues for the three-month period ended on
March 31, 2022. Genesys Membrane Products, S.L.U.
(“GMP”), which was acquired on February 1, 2021,
contributed $2.2 M in revenues for the three-month period ended on
March 31, 2022, compared to $1.5 M for the same quarter of
fiscal year 2021.
(In thousands of Canadian dollars) |
Three-month periods ended March 31, |
Nine-month periods ended March 31, |
2022 |
2021 |
2022 |
2021 |
|
$ |
% (a) |
$ |
% (a) |
$ |
% (a) |
$ |
% (a) |
Revenues per business pillar |
|
|
|
|
|
|
|
|
WTS |
11,892 |
22.9 |
10,095 |
25.7 |
29,442 |
22.3 |
23,281 |
21.3 |
Specialty Products |
15,909 |
30.6 |
11,810 |
30.2 |
41,038 |
31.0 |
33,586 |
30.8 |
O&M |
24,116 |
46.5 |
17,250 |
44.1 |
61,830 |
46.7 |
52,253 |
47.9 |
Total revenues |
51,917 |
100.0 |
39,155 |
100.0 |
132,310 |
100.0 |
109,120 |
100.0 |
|
|
|
|
|
|
|
|
|
Gross profit margin before depreciation and amortization |
14,128 |
27.2 |
11,081 |
28.3 |
36,144 |
27.3 |
29,943 |
27.4 |
SG&A expenses(b) |
9,098 |
17.5 |
6,497 |
16.6 |
23,709 |
17.9 |
18,546 |
17.0 |
Net earnings for the period |
1,330 |
2.6 |
2,062 |
5.3 |
2,710 |
2.0 |
3,314 |
3.0 |
EBITDA2 |
4,382 |
8.4 |
5,347 |
13.7 |
11,082 |
8.4 |
11,279 |
10.3 |
Adjusted EBITDA2 |
5,332 |
10.3 |
4,513 |
11.5 |
13,149 |
9.9 |
11,557 |
10.6 |
Adjusted net earnings2 |
3,378 |
6.5 |
2,181 |
5.6 |
7,269 |
5.5 |
6,014 |
5.5 |
Recurring revenues3 |
43,311 |
83.4 |
32,339 |
82.6 |
112,969 |
85.4 |
95,070 |
87.1 |
- % of total revenues.
- Selling, general and administrative expenses (“SG&A”).
WTS’s financial performance for the third
quarter of fiscal year 2022 was characterized by a 17.8% growth in
revenues, coupled with an improved gross profit margin at 23.0% for
the third quarter of fiscal year 2022, compared to 19.2% for the
same quarter of last year.
Specialty Products’s EBAC4 increased by 31.1%
for the third quarter of fiscal year 2022, driven by higher sales
coming from specialty chemical products and Piedmont business line.
Specialty Products also faced challenges caused by supply chain
issues and logistic. The Specialty Products pillar depends on the
import and export of goods and had to deal with global supply chain
delays and increased costs of materials.
During the third quarter of fiscal year 2022,
the O&M business pillar showed organic revenue growth of 13.4%
but was offset by the reduction of the gross profit margin in %
partly due to the consequences of the COVID-19 pandemic. In the
last twelve months, the O&M business pillar gained four new
projects as well as scope expansions. Generally, start-up of new
projects begins at lower gross profit margins because of training
and initial setup, after which margins grow progressively. The
O&M gross profit margin was also affected by the consequences
of the COVID-19 pandemic, such as the pressure on employee salaries
due to staff shortage, sick leave related to COVID-19 within the
staff and the increases in insurance costs.
The Corporation’s gross profit margin before
depreciation and amortization stood at $14.1 M, or 27.2%, during
the third quarter of fiscal year 2022, compared to $11.1 M, or
28.3% for the previous fiscal year, representing an increase of
$3.0 M, or 27.5%. The percentage decrease is explained by
reduced gross profit margins in the Specialty Products and O&M
business pillars, partly compensated by the improved gross profit
margin in WTS. Specialty Products and O&M were the business
pillars mostly affected by the impacts resulting from the pandemic,
namely the costs arising from sick leave and the increased cost of
materials. H2O Innovation’s business model relies on three
different business pillars enabling it to reduce the volatility of
the Corporation’s profitability through diversification.
The Corporation’s SG&A totalled $9.1 M
during the third quarter of fiscal year 2022, compared to $6.5 M
for the same period of the previous fiscal year, which represents
an increase of $2.6 M, or 40.0%, while the revenues of the
Corporation increased by 32.6%. The acquisition of GMP on February
1, 2021, and the acquisition of JCO and EC on
December 15, 2021, contributed $0.4 M of this increase.
The remainder of the increase is due to hiring of additional
resources in the sales and human resources departments, resumption
of travel activities, higher professional fees, as well as higher
stock-based compensation costs and insurance costs, compared to the
same quarter of the last fiscal year. The Corporation also incurred
uplisting fees of $0.2 M following the listing of its common
shares on the TSX in March 2022.
The Corporation’s adjusted EBITDA increased by
$0.8 M, or 18.1%, to reach $5.3 M during the third quarter of
fiscal year 2022, from $4.5 M for the comparable period of fiscal
year 2021. The adjusted EBITDA % decreased to 10.3% for the third
quarter of fiscal year 2022, compared to 11.5% for the same quarter
of last fiscal year, mostly due to the aforementioned consequences
resulting from the COVID-19 pandemic. The reduction of the adjusted
EBITDA % resulted from the decrease in the Corporation’s
consolidated gross profit margin and the increase of the SG&A
ratio to support the growth of the Corporation as presented in the
three-year strategic plan. The Corporation’s profitability has been
impacted by the current global consequences of the COVID-19
pandemic, as previously stated.
Net earnings amounted to $1.3 M and $0.015 per
share for the third quarter of fiscal year 2022 compared to net
earnings of $2.1 M and $0.026 per share for the comparable quarter
of fiscal year 2021. Adjusted net earnings amounted to $3.4 M
and $0.038 per share for the third quarter of fiscal year 2022
compared to adjusted net earnings of $2.2 M and $0.027 per
share for the comparable quarter of fiscal year 2021.
Nine-month results
Revenues stood at $132.3 M, compared to $109.1 M
last year, driven by organic revenue growth of $13.0 M, or
11.9%, and acquisition growth of $12.4 M, or 11.3%, offset by an
unfavourable USD exchange rate impact of $2.2 M, or 1.9%; gross
margin was $36.1 M, or 27.3%, compared to $29.9 M, or 27.4% last
year; adjusted EBITDA was $13.1 M, or 9.9%, compared to $11.6 M, or
10.6% last year; and net earnings were $2.7 M, or $0.031 per share,
compared to net earnings of $3.3 M, or $0.042 per share last
year, essentially for the same reasons mentioned for the third
quarter.
Non-IFRS financial
measurements
EBITDA and adjusted EBITDA
EBITDA means earnings before finance costs –
net, income taxes, depreciation and amortization. The definition of
adjusted EBITDA excludes expenses otherwise considered in net
earnings according to Generally Accepted Accounting Principles
(“GAAP”), namely the unrealized exchange (gains) losses, the change
in fair value of contingent considerations and the stock-based
compensation costs, the fair value gain on step acquisition and
litigation provision. These items are non-cash items and do not
have an impact on the operating and financial performance of the
Corporation. Management has also elected to exclude the acquisition
and integration costs, as they are not directly linked to the
operations. The reader can establish the link between adjusted
EBITDA and net earnings based on the reconciliation presented
below. The definition of adjusted EBITDA used by the Corporation
may differ from those used by other companies. Even though adjusted
EBITDA is a non-IFRS measure, it is used by management to make
operational and strategic decisions. Providing this information to
the stakeholders, in addition to the GAAP measures, allows them to
see the Corporation’s results through the eyes of management, and
to better understand the financial performance, notwithstanding the
impact of GAAP measures.
Reconciliation of net earnings to EBITDA
and to adjusted EBITDA
(In thousands of Canadian dollars) |
Three-month periods ended March 31, |
Nine-month periods ended March 31, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
|
$ |
$ |
$ |
$ |
Net earnings for the period |
1,330 |
|
2,062 |
|
2,710 |
|
3,314 |
|
Finance costs – net |
556 |
|
862 |
|
1,606 |
|
1,975 |
|
Income taxes |
39 |
|
590 |
|
262 |
|
529 |
|
Depreciation of property, plant and equipment and right-of-use
assets |
938 |
|
789 |
|
2,690 |
|
2,367 |
|
Amortization of intangible assets |
1,519 |
|
1,044 |
|
3,814 |
|
3,094 |
|
EBITDA |
4,382 |
|
5,347 |
|
11,082 |
|
11,279 |
|
|
|
|
|
|
Unrealized exchange (gain) loss |
(113 |
) |
(3 |
) |
(665 |
) |
639 |
|
Stock-based compensation costs |
330 |
|
39 |
|
823 |
|
121 |
|
Changes in fair value of the contingent considerations |
496 |
|
615 |
|
1,451 |
|
719 |
|
Acquisition and integration costs |
237 |
|
212 |
|
458 |
|
496 |
|
Fair value gain on step acquisition |
- |
|
(2,347 |
) |
- |
|
(2,347 |
) |
Litigation provision |
- |
|
650 |
|
- |
|
650 |
|
Adjusted EBITDA |
5,332 |
|
4,513 |
|
13,149 |
|
11,557 |
|
Adjusted net earnings
The definition of adjusted net earnings excludes
acquisition and integration costs, amortization of intangible
assets from acquisition, unrealized exchange (gain) loss, change in
fair value of the contingent considerations, stock-based
compensation costs, fair value gain on step acquisition, litigation
provision, and realized net (gain) loss on swap termination. The
reader can establish the link between net earnings and adjusted net
earnings with the reconciliation items presented in this report.
The definition of adjusted net earnings used by the Corporation may
differ from those used by other companies. Adjusted net earnings
and adjusted net earnings per share are non-IFRS measure and they
are used by management to monitor financial performance and to make
strategic decisions.
Reconciliation of net earnings to
adjusted net earnings
(In thousands of Canadian dollars) |
Three-month periods ended March 31, |
Nine-month periods ended March 31, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
|
$ |
$ |
$ |
$ |
Net earnings for the period |
1,330 |
|
2,062 |
|
2,710 |
|
3,314 |
|
Acquisition and integration costs |
237 |
|
212 |
|
458 |
|
496 |
|
Amortization of intangible assets related to business
combinations |
1,442 |
|
931 |
|
3,549 |
|
2,853 |
|
Unrealized exchange (gain) loss |
(113 |
) |
(3 |
) |
(665 |
) |
639 |
|
Changes in fair value of the contingent considerations |
496 |
|
615 |
|
1,451 |
|
719 |
|
Stock-based compensation costs |
330 |
|
39 |
|
823 |
|
121 |
|
Fair value gain on step acquisition |
- |
|
(2,347 |
) |
- |
|
(2,347 |
) |
Litigation provision |
- |
|
650 |
|
- |
|
650 |
|
Realized net (gain) loss on interest rate swap termination |
- |
|
237 |
|
(237 |
) |
237 |
|
Income taxes related to above items |
(344 |
) |
(215 |
) |
(820 |
) |
(668 |
) |
Adjusted net earnings |
3,378 |
|
2,181 |
|
7,269 |
|
6,014 |
|
Recurring revenues
Recurring revenue by nature is a non-IFRS
measure and is defined by management as the portion of the
Corporation’s revenue coming from customers with whom the
Corporation has established a long-term relationship and/or coming
from a business with a recurring customer sales pattern. However,
there is no guarantee that recurring revenues will last
indefinitely. The Corporation’s recurring revenues are coming from
the Specialty Products and O&M business pillars as well as the
service activities of the WTS business pillar. Revenues excluded
from the definition of “recurring revenue by nature” come from
water treatment system projects which are characterized by the
lumpiness factor. This non-IFRS measure is used by management to
evaluate the stability of revenues from one year to the other. The
definition of recurring revenues by nature used by the Corporation
may differ from those used by other companies.
Organic revenue growth
Three-month period ended March 31, 2022 |
(In thousands of Canadian dollars) |
|
2022 Revenues |
2021 Revenues |
Variation |
Foreign exchangeimpact |
Acquisitionsimpact |
Organicrevenue growth |
|
$ |
$ |
$ |
% |
$ |
% |
$ |
% |
$ |
% |
WTS |
11,892 |
10,095 |
1,797 |
17.8 |
- |
- |
- |
- |
1,797 |
17.8 |
Specialty Products |
15,909 |
11,810 |
4,099 |
34.7 |
1 |
0.0 |
2,238 |
19.0 |
1,860 |
15.7 |
O&M |
24,116 |
17,250 |
6,866 |
39.8 |
3 |
0.0 |
4,543 |
26.3 |
2,320 |
13.4 |
Total revenues |
51,917 |
39,155 |
12,762 |
32.6 |
4 |
0.0 |
6,781 |
17.3 |
5,977 |
15.3 |
H2O
Innovation conference call
Frédéric Dugré, President and Chief Executive
Officer, and Marc Blanchet, Chief Financial Officer, will hold an
investor conference call to discuss the third quarter financial
results in further details at 10:00 a.m. Eastern Time on
Thursday, May 12, 2022.
To access the call, please call 1-888-440-2131
or 438-803-0534, five to ten minutes prior to the start time.
Presentation slides for the conference call will be made available
on the Corporate Presentations page of the Investors section of the
Corporation’s website.
The third-quarter financial report is
available on www.h2oinnovation.com. Additional information on the
Corporation is also available on SEDAR
(www.sedar.com).
Prospective disclosures Certain
statements set forth in this press release regarding the operations
and the activities of H2O Innovation as well as other
communications by the Corporation to the public that describe more
generally management objectives, projections, estimates,
expectations or forecasts may constitute forward-looking statements
within the meaning of securities legislation. Forward-looking
statements include the use of the words such as “anticipate,” “if,”
“believe,” “continue,” “could,” “estimate,” “expect,” “intend,”
“may,” “plan,” “potential,” “predict,” “project,” “should” or
“will” and other similar terms as well as those usually used in the
future and the conditional. Forward-looking statements concern
analysis and other information based on forecast future results and
the estimate of amounts that cannot yet be determined and are based
on the estimates and opinions of management on the date the
statements are made.
In this press release, such forward-looking
statements include, but are not limited to, statements regarding
the Corporation’s ability to grow its business and to reach
specific financial objectives and targets and involve several risks
and uncertainties. Those risks and uncertainties include, without
limitations, the Corporation’s ability to maintain its financial
position and its business improvements and to complete and execute
projects and deliveries in due time and as expected by the
customers, despite the challenges and impacts of the COVID-19
pandemic. Information about the risk factors to which the
Corporation is exposed is provided in the Annual Information Form
dated September 27, 2021, which is available on SEDAR
(www.sedar.com).
Should one or more of these risks or
uncertainties materialize or should the assumptions underlying
those forward-looking statements prove incorrect, actual results
may vary materially from those described herein. Unless required to
do so pursuant to applicable securities legislation, H2O Innovation
assumes no obligation to update or revise forward-looking
statements contained in this press release or in other
communications as a result of new information, future events, and
other changes.
About
H2O Innovation
Innovation is in our name, and it is what drives
the organization. H2O Innovation is a complete water solutions
company focused on providing best-in-class technologies and
services to its customers. The Corporation’s activities rely on
three pillars: i) Water Technologies & Services (WTS) applies
membrane technologies and engineering expertise to deliver
equipment and services to municipal and industrial water,
wastewater, and water reuse customers, ii) Specialty Products (SP)
is a set of businesses that manufacture and supply a complete line
of specialty chemicals, consumables and engineered products for the
global water treatment industry, and iii) Operation &
Maintenance (O&M) provides contract operations and associated
services for water and wastewater treatment systems. Through
innovation, we strive to simplify water. For more information,
visit www.h2oinnovation.com.
Source: H2O Innovation Inc.
www.h2oinnovation.com Contact: Marc Blanchet
+1 418-688-0170 marc.blanchet@h2oinnovation.com 1 These
non-IFRS measures are presented as additional information and
should be used in conjunction with the IFRS financial measurements
presented in this press release. Definition of all non-IFRS
measures and additional IFRS measures are provided at the end of
this press release in section “Non-IFRS financial measurements“ to
give the reader a better understanding of the indicators used by
management. 2 Organic revenue is a non-IFRS financial measure
corresponding to the amount of revenue of a given period, excluding
the effect of acquisitions and foreign currency changes of the same
period. Organic revenue growth is a non-IFRS ratio calculated by
comparing the amount of organic revenue of a given period with the
amount of revenue of the comparative period. 3 These non-IFRS
measures are presented as additional information and should be used
in conjunction with the IFRS financial measurements presented in
this press release. Definition of all non-IFRS measures and
additional IFRS measures are provided at the end of this press
release in section “Non‑IFRS financial measurements” to give the
reader a better understanding of the indicators used by management.
4 The definition of EBAC means the earnings before depreciation and
amortization reduced by the selling and general expenses. EBAC is a
non-IFRS measure and it is used by management to monitor financial
performance and to make strategic decisions. The definition of EBAC
used by the Corporation may differ from those used by other
companies.
H2O Innovation (TSXV:HEO)
Historical Stock Chart
From Dec 2024 to Jan 2025
H2O Innovation (TSXV:HEO)
Historical Stock Chart
From Jan 2024 to Jan 2025